GN Store Nord A/S/DKr GN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About GN Store Nord A/S
GN Store Nord A/S is a Danish company specializing in audio solutions and hearing aids, operating within the technology and healthcare industries. It provides a range of products, including hearing aids through its GN Hearing division and audio communications for consumer and professional markets through GN Audio, known for brands like Jabra. Founded in 1869 with a history rooted in telecommunication technology, the company is headquartered in Ballerup, Denmark. GN Store Nord leverages its expertise in sound processing and wireless technology to maintain a competitive edge in delivering innovative auditory products. Its extensive geographic reach and R&D investments support its strategic goals in multiple international markets.
- Ticker
- DKr GN
- Sector
- Consumer Discretionary
- Primary listing
- CSE
- Employees
- 7,744
- Headquarters
- Ballerup, Denmark
- Website
- www.gn.com
GN Metrics
BasicAdvanced
kr 16B
-
-kr 3.85
1.42
-
Price and volume
Market cap
kr 16B
Beta
1.42
52-week high
kr 123.75
52-week low
kr 85.12
Average daily volume
555K
Financial strength
Current ratio
1.933
Quick ratio
0.379
Long term debt to equity
0.79
Total debt to equity
1.027
Interest coverage (TTM)
2.85%
Profitability
EBITDA (TTM)
1,303
Gross margin (TTM)
54.66%
Net profit margin (TTM)
-3.40%
Operating margin (TTM)
7.00%
Effective tax rate (TTM)
22.30%
Revenue per employee (TTM)
kr 2,130,000
Management effectiveness
Return on assets (TTM)
2.44%
Return on equity (TTM)
2.15%
Valuation
Price to revenue (TTM)
0.945
Price to book
1.51
Price to tangible book (TTM)
51.81
Price to free cash flow (TTM)
30.256
Free cash flow yield (TTM)
3.31%
Free cash flow per share (TTM)
3.53
Growth
Revenue change (TTM)
19.58%
Earnings per share change (TTM)
-164.09%
3-year revenue growth (CAGR)
-3.95%
10-year revenue growth (CAGR)
7.25%
3-year earnings per share growth (CAGR)
4.63%
10-year earnings per share growth (CAGR)
-5.04%
What the Analysts think about GN
Analyst ratings (Buy, Hold, Sell) for GN Store Nord A/S stock.
Analyst projections of the future price of GN Store Nord A/S stock.
Bulls say / Bears say
GN raised its 2026 adjusted EBITA margin target to 9–10% from 8–9%, after Q2 gross margin improved to 57.2% from 56.1%. This points to better pricing and cost control, even before the planned cost savings take effect. (GN Store Nord, Nasdaq)
Gaming grew organically by 5% in Q2 as Nova Pro Omni helped GN gain headset market share. Its divisional profit margin also rose to 15.0% from 12.2%, suggesting this business can grow while improving profitability. (GN Store Nord)
The planned sale of Hearing to Amplifon would bring DKK 12.6bn in cash plus Amplifon shares, an important source of funds to reduce debt and invest in the remaining businesses. GN’s Q2 report says the proceeds would leave it with negative net debt on a pro forma basis, though the deal still needs to close. (GN Store Nord)
Continuing-operations revenue fell 6% year on year in Q2, with organic growth at -4%, and adjusted EBITA dropped 33%. GN cut its 2026 organic growth outlook to 0–3% from 0–6%, pointing to continued difficulty turning new products into sales. (GN Store Nord, Nasdaq)
The higher margin target partly relies on DKK 100–150m of expected US tariff refunds in the second half. That is a temporary boost, while the company’s organic revenue outlook was narrowed, so the stronger margin forecast may overstate the underlying improvement. (Nasdaq)
The balance sheet remains stretched before the Hearing sale closes: net debt was DKK 9.6bn and adjusted leverage was 4.4x at Q2, while free cash flow excluding M&A was negative DKK 616m. Any delay to the transaction would postpone the expected debt relief. (GN Store Nord)
Data summarised monthly by Lightyear AI. Last updated on 13 Oct 2026.
GN Financial Performance
Revenues and expenses
GN Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing GN
AllUSDEURGBP
Fund name | Fund size | DKr GN weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.14% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.14% |
Vanguard ESG Developed Europe All Cap£V3EA | €125M | 0.02% |
Vanguard ESG Developed Europe All Cap£V3EL | €35M | 0.02% |
iShares MSCI World Small Cap£WLDS | $9B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.